With over 20 years’ experience in health care management and consultancy, Mr Roumeliotis has undertaken a wide range of assignments in the public and private health care sectors in the US, Europe, MENA, Baltics, LATAM & APAC. He has experience in strategic planning, functional, marketing and communication planning. Has a substantial track record in managing stakeholders, payers, doctors, designing and executing healthcare marketing plans and selling healthcare services to private and public HMOs. He has expertise in the establishment and development of primary care centers and the design and application of architected sales solutions for hospital networks.

 

As of early 2000s Mr Roumeliotis has been a pioneer in the establishment and development of biobanking and cell therapy preclinical services starting from the EU - MENA region and continuously contributes in the formulation of a sustainable and ethical policy and regulatory framework for this innovative industry.

 

Based on this network and platform, as of 2013 accomplished a step further towards advancing precision medicine, disease prevention and affordable consumer health care.

He contributed and managed the creation and development of Genoma

a Swiss company in proteomics and genomics for predictive medicine with the first genetic platform for clinical diagnostics in Europe utilizing the latest NGS technologies.

 

Over the past 6 years further paved his career into precision medicine initiatives, digital and connected health. Relocated to the US and served as the Director of Global Strategic Partnerships at Veritas Genetics, The Genome Company. Next step was moving into the lab and cloud agnostic world

today serves as VP of Global Bus Development at Orgenesis Inc., helping to bring advanced personalized cell and gene therapies (CGTs) therapies to market effectively, with Orgenesis's unique Orgenesis Mobile Processing Units and Labs™ - OMPUL™ providing decentralized production of advanced therapies at the of POCare™ Services Providing Platform.